Dr Reddys to sell Finast, Styptovit-E and 2 other brands to Torrent Pharma Ruchika Sharma27 May 2022 12:21 PM ISTAs per the terms of the definitive agreement, Torrent Pharma will take over the manufacturing, marketing and distribution of these brands in India.
Dr Reddys, Senores Pharma unveil Ketorolac Tromethamine Tablets in US Ruchika Sharma25 May 2022 11:57 AM ISTDr. Reddy’s Ketorolac Tromethamine Tablets USP, 10 mg, are available in bottle count sizes of 100.
Dr Reddys Labs, HK inno.N Corporation ink pact to commercialize Tegoprazan in India, 6 key emerging Markets Ruchika Sharma12 May 2022 12:19 PM ISTThe agreement grants Dr. Reddy's the exclusive rights to develop and commercialise Tegoprazan under its own trademark in these markets for 10 years...
India allows export of Hetero Biopharma produced Sputnik Light Ruchika Sharma11 Oct 2021 2:09 PM ISTNew Delhi: The government has permitted the export of Russia's single-dose Covid-19 vaccine Sputnik Light domestically produced here as the jab has...
NPPA fixes retail price of 23 formulations; details Medical Dialogues Team27 Sept 2021 4:37 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Covid-19: India likely to allow export of Sputnik Light this month Ruchika Sharma24 Sept 2021 10:00 AM ISTNew Delhi: India is likely to allow the export of domestically produced doses of Russia's Sputnik Light COVID-19 vaccine this month, as the shot has...
DRDO grants license to Mankind Pharma for COVID drug 2-DG Farhat Nasim8 July 2021 5:47 PM ISTNew Delhi: Drug firm Mankind Pharma on Thursday said it has received licence from the Defence Research and Development Organisation (DRDO) to...
WHO team flags concerns on Sputnik V vaccine filling plant in Russia Ruchika Sharma24 Jun 2021 1:30 PM ISTNew Delhi: A WHO team has flagged concerns on a Sputnik V vaccine filling plant in Russia and other issues after its officials inspected the facility...
Dr Reddys told to pay around Rs 339 crore to Hatchtech Medical Dialogues Team17 Jun 2021 1:00 PM ISTNew Delhi: Dr Reddy's Laboratories on Tuesday said it has been asked to pay USD 46.25 million (around Rs 339 crore) to Australia-based Hatchtech Pty...
DRDO invites Indian pharma firms for bulk production of COVID drug 2DG Medical Dialogues Team10 Jun 2021 6:26 PM ISTNew Delhi: The Defence Research and Development Organisation (DRDO) has called for an Expression of Interest (EoI) for Transfer of Technology (ToT)...
BMC in talks with Dr Reddys after rejecting all 9 vaccine supply bids Medical Dialogues Team7 Jun 2021 10:15 AM ISTMumbai: After rejecting all nine bids from facilitator firms for procurement of 1 crore Covid-19 vaccine doses for Mumbai due to insufficient...
NPPA directs Cipla, Sun Pharma, others to reduce Remdesivir MRP Medical Dialogues Team17 April 2021 4:13 PM ISTNew Delhi: With the demands of Covid-19 drug Remdesivir shooting up, the National Pharmaceutical Pricing Authority (NPPA) has directed drugmakers...
